iifl-logo

Orchid Pharma Ltd Board Meeting

796.95
(1.79%)
Apr 2, 2025|02:29:58 PM

Orchid Pharma CORPORATE ACTIONS

02/04/2024calendar-icon
02/04/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting12 Feb 20256 Feb 2025
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the un-audited Limited Reviewed Financial Results for the Quarter III of Financial Year 2024-25 ended on December 31 2024. Outcome of Board meeting held for ,inter alia, consideration and approval of Unaudited Limited Reviewed Financial Results (Standalone and Consolidated) for the Quarter ended December 31, 2024. (As Per BSE Announcement Dated on: 12/02/2025)
Board Meeting11 Nov 20245 Nov 2024
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve the Unaudited Limited Reviewed Financial Results (Standalone and Consolidated) of the Company for quarter II and half year ended on September 30 2024 of Financial Year 2024-25. Outcome of Board Meeting held on November 11, 2024 (As Per BSE Announcement Dated on: 11/11/2024)
Board Meeting12 Aug 20246 Aug 2024
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) of the Company for the Quarter-1 of financial year 2024-25 ended on June 30 2024 Financial Results for the quarter ended June 2024 (As per BSE Announcement dated on 12/08/2024)
Board Meeting19 Jul 202417 Jul 2024
Outcome of Board Meeting w.r.t the Re-appointment of Directors and other matters as disclosed in the letter. Considered and approved the Board Report and annexures thereto for the F.Y.2023-24 and Notice of the AGM to be held on August 21, 2024. (As Per BSE Announcement dated on 19.07.2024)
Board Meeting23 May 202416 May 2024
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 inter alia to consider and approve Audited Standalone & Consolidated Financial Results of the Company for the quarter and financial year ended on March 31 2024. Statement on Nil Deviation or Variation for proceeds of Qualified Institutions Placement for Quarter ended March 31, 2024 Audited Financial Results along with Auditors Report for Financial Year ended on March 31, 2024 outcome of the Board Meeting held on May 23, 2024 (As Per BSE Announcement dated on 23.05.2024)

Orchid Pharma: Related News

Orchid Pharma Clears USFDA Inspection, Secures EU GMP Renewal
20 Feb 2025|03:36 PM

The inspection raised, seven minor observations none related to data integrity, and therefore, the facility remains compliant under stringent regulatory standards.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.